- Home
- Euronext Brussel
- Company regulated news
- Archive
- Company press releases
Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
12 Mar 2024 08:30 CET |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 04/03/2024 tot 08/03/2024 | 30202010 Asset Managers and Custodians | Other subject |
12 Mar 2024 08:30 CET |
CIE BOIS SAUVAGE | Cie du Bois Sauvage: Buy back of own shares – week from 04/03/2024 to 08/03/2024 | 30202010 Asset Managers and Custodians | Other subject |
12 Mar 2024 08:00 CET |
KBC | KBC Groupe: Mise à jour concernant le programme de rachat d’actions propres de KBC Groupe | 30101010 Banks | Other subject |
12 Mar 2024 08:00 CET |
KBC | KBC Groep: Update m.b.t. inkoopprogramma van KBC Groep voor eigen aandelen | 30101010 Banks | Other subject |
12 Mar 2024 08:00 CET |
KBC | KBC Group: Update regarding the KBC Group share buyback programme | 30101010 Banks | Other subject |
12 Mar 2024 07:00 CET |
SYENSQO | Resultaten Syensqo - jaar 2023 | 55101000 Diversified Materials | Corporate life |
12 Mar 2024 07:00 CET |
SYENSQO | Syensqo full-year 2023 results | 55101000 Diversified Materials | Corporate life |
12 Mar 2024 07:00 CET |
BIOSENIC | BioSenic releases details of optimized administration approach ahead of planned Phase 3 trial of OATO for chronic graft-versus-host disease | 20103010 Biotechnology | Corporate life |
12 Mar 2024 07:00 CET |
SYENSQO | Résultats de l'année 2023 de Syensqo | 55101000 Diversified Materials | Corporate life |
12 Mar 2024 07:00 CET |
BIOSENIC | BioSenic publie les détails de la stratégie d'administration optimisée pour OATO dans le traitement de la maladie chronique du greffon contre l'hôte en amont du prochain essai de phase 3 | 20103010 Biotechnology | Corporate life |
12 Mar 2024 06:00 CET |
NYRSTAR | Nyrstar NV – Verzoekschrift voor voorlopige maatregelen ontvangen op 11 maart 2024 | 55102050 Nonferrous Metals | Other subject |
12 Mar 2024 06:00 CET |
NYRSTAR | Nyrstar NV – Petition for interim measures received on 11 March 2024 | 55102050 Nonferrous Metals | Other subject |
11 Mar 2024 18:09 CET |
GBL | GBL - Transacties op GBL-aandelen 11-03-2024 | 30202000 Diversified Financial Services | Other financial transaction |
11 Mar 2024 18:08 CET |
GBL | GBL - Transactions sur actions propres 11-03-2024 | 30202000 Diversified Financial Services | Other financial transaction |
11 Mar 2024 18:07 CET |
GBL | GBL - Transactions on GBL shares 11-03-2024 | 30202000 Diversified Financial Services | Other financial transaction |
11 Mar 2024 18:00 CET |
AZELIS GROUP NV | Azelis Launches Share Buyback Program 2024 under its Long-term Incentive Plan | 55201000 Chemicals: Diversified | Other financial transaction |
11 Mar 2024 18:00 CET |
AZELIS GROUP NV | Azelis kondigt Aandeleninkoopprogramma 2024 aan onder zijn langetermijnstimulusplan | 55201000 Chemicals: Diversified | Other financial transaction |
11 Mar 2024 08:35 CET |
TITAN CEMENT | Programme de rachats d'actions | 50101030 Cement | Other subject |
11 Mar 2024 08:35 CET |
TITAN CEMENT | Share buyback programme | 50101030 Cement | Other subject |
11 Mar 2024 07:30 CET |
ONWARD MEDICAL | ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System | 20101025 Health Services | - |
11 Mar 2024 07:14 CET |
JENSEN-GROUP | Inkoop eigen aandelen - wekelijkse update | 50204000 Machinery: Industrial | Other subject |
11 Mar 2024 07:13 CET |
JENSEN-GROUP | Share buyback – weekly update | 50204000 Machinery: Industrial | Other subject |
08 Mar 2024 09:37 CET |
ATENOR | Atenor kondigt de benoeming van Caroline Vanderstraeten aan als CFO toevoegen | 35101010 Real Estate Holding and Development | Journal / appointments |
08 Mar 2024 09:35 CET |
ATENOR | Atenor annonce la nomination de Caroline Vanderstraeten en tant que CFO | 35101010 Real Estate Holding and Development | Journal / appointments |
08 Mar 2024 09:33 CET |
ATENOR | Atenor announces appointment of Caroline Vanderstraeten as CFO | 35101010 Real Estate Holding and Development | Journal / appointments |
08 Mar 2024 08:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: publication of a transparency notification | 35102030 Office REITs | Change in Capital |
08 Mar 2024 08:00 CET |
KBC | KBC Groep: Transparantiekennisgeving met betrekking tot het aandeleninkoop-programma van KBC Groep | 30101010 Banks | Other subject |
08 Mar 2024 08:00 CET |
KBC | KBC Group: Transparency notification regarding the KBC Group share buyback programme | 30101010 Banks | Other subject |
08 Mar 2024 08:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: publication of a transparency notification | 35102030 Office REITs | Change in Capital |
08 Mar 2024 08:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: publication of a transparency notification | 35102030 Office REITs | Change in Capital |
08 Mar 2024 08:00 CET |
KBC | KBC Groupe: Notification de transparence concernant le programme de rachat d'actions propres du groupe KBC | 30101010 Banks | Other subject |
08 Mar 2024 07:00 CET |
HYLORIS | Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024 | 20103010 Biotechnology | Commercial results |
08 Mar 2024 07:00 CET |
MITHRA | Mithra reports full year 2023 financial results | 20103015 Pharmaceuticals | - |
08 Mar 2024 07:00 CET |
HYLORIS | Hyloris to Report 2023 Full-Year Results on 14 March 2024 | 20103010 Biotechnology | Commercial results |
07 Mar 2024 22:01 CET |
ARGENX SE | argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting | 20103010 Biotechnology | Other subject |
07 Mar 2024 19:00 CET |
OXURION | Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC | 20103010 Biotechnology | - |
07 Mar 2024 18:18 CET |
VIOHALCO | Conférence téléphonique portant sur les résultats financiers 2023 | 55102015 Metal Fabricating | Meetings / events |
07 Mar 2024 18:18 CET |
VIOHALCO | Financial results 2023 Conference Call | 55102015 Metal Fabricating | Meetings / events |
07 Mar 2024 18:03 CET |
VIOHALCO | Proposition de distribution de dividende et mise à jour du calendrier financier 2024 | 55102015 Metal Fabricating | Dividend |
07 Mar 2024 18:02 CET |
VIOHALCO | Proposal of a Dividend Distribution and Update of Financial Calendar 2024 | 55102015 Metal Fabricating | Dividend |
07 Mar 2024 18:01 CET |
PAYTON PLANAR MAGNETICS | AGM announcement | 50202010 Electrical Components | Meetings / events |
07 Mar 2024 18:00 CET |
VAN DE VELDE | VAN DE VELDE : inkoop eigen aandelen | 40204020 Clothing and Accessories | Other subject |
07 Mar 2024 18:00 CET |
VAN DE VELDE | VAN DE VELDE : acquisition of treasury shares | 40204020 Clothing and Accessories | Other subject |
07 Mar 2024 17:52 CET |
VIOHALCO | Viohalco résultats financiers consolidés de l’exercice clos le 31 décembre 2023 | 55102015 Metal Fabricating | Commercial results |
07 Mar 2024 17:49 CET |
JENSEN-GROUP | Recordopbrengsten, winst en strategische investeringen in 2023 | 50204000 Machinery: Industrial | Other subject |
07 Mar 2024 17:49 CET |
VIOHALCO | Viohalco consolidated financial results for the year ended 31 December 2023 | 55102015 Metal Fabricating | Commercial results |
07 Mar 2024 17:48 CET |
JENSEN-GROUP | Record revenue, profit and strategic investments in 2023 | 50204000 Machinery: Industrial | Other subject |
07 Mar 2024 12:00 CET |
EVS BROADC.EQUIPM. | EVS joins BEL ESG Index, reinforcing commitment to sustainability | 15101010 Telecommunications Equipment | Corporate life |
07 Mar 2024 07:00 CET |
AZELIS GROUP NV | FY2023 Results: Azelis Delivers Record Free Cash Flow | 55201000 Chemicals: Diversified | Commercial results |
07 Mar 2024 07:00 CET |
AZELIS GROUP NV | Resultaten 2023: vrije kasstroom Azelis bereikt recordhoogte | 55201000 Chemicals: Diversified | Commercial results |